BRPI1009829A2 - combinações de proteína de ligação de fator h meningocócico e conjugados de sacarídeos pneumocócicos - Google Patents
combinações de proteína de ligação de fator h meningocócico e conjugados de sacarídeos pneumocócicosInfo
- Publication number
- BRPI1009829A2 BRPI1009829A2 BRPI1009829A BRPI1009829A BRPI1009829A2 BR PI1009829 A2 BRPI1009829 A2 BR PI1009829A2 BR PI1009829 A BRPI1009829 A BR PI1009829A BR PI1009829 A BRPI1009829 A BR PI1009829A BR PI1009829 A2 BRPI1009829 A2 BR PI1009829A2
- Authority
- BR
- Brazil
- Prior art keywords
- meningococcal
- binding protein
- factor binding
- saccharide conjugates
- protein combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16300509P | 2009-03-24 | 2009-03-24 | |
US27040709P | 2009-07-07 | 2009-07-07 | |
PCT/IB2010/000734 WO2010109324A1 (en) | 2009-03-24 | 2010-03-24 | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1009829A2 true BRPI1009829A2 (pt) | 2016-11-16 |
Family
ID=42470802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1009829A BRPI1009829A2 (pt) | 2009-03-24 | 2010-03-24 | combinações de proteína de ligação de fator h meningocócico e conjugados de sacarídeos pneumocócicos |
Country Status (11)
Country | Link |
---|---|
US (1) | US20120064103A1 (pt) |
EP (2) | EP2411045A1 (pt) |
JP (2) | JP5668049B2 (pt) |
CN (1) | CN102438649A (pt) |
AU (1) | AU2010227220B2 (pt) |
BR (1) | BRPI1009829A2 (pt) |
CA (1) | CA2756533A1 (pt) |
CL (2) | CL2011002369A1 (pt) |
NZ (1) | NZ595291A (pt) |
RU (1) | RU2555757C2 (pt) |
WO (1) | WO2010109324A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
NZ595234A (en) | 2009-03-24 | 2013-12-20 | Novartis Ag | Adjuvanting meningococcal factor h binding protein |
EP2585106A1 (en) * | 2010-06-25 | 2013-05-01 | Novartis AG | Combinations of meningococcal factor h binding proteins |
WO2012025873A2 (en) | 2010-08-23 | 2012-03-01 | Wyeth Llc | STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS |
JP5976652B2 (ja) | 2010-09-10 | 2016-08-24 | ワイス・エルエルシー | 髄膜炎菌orf2086抗原の非脂質化変異体 |
EP3485906A1 (en) | 2012-03-09 | 2019-05-22 | Pfizer Inc | Neisseria meningitidis compositions and methods thereof |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
MX2014014067A (es) * | 2012-05-22 | 2015-02-04 | Novartis Ag | Conjugado de serogrupo x de meningococo. |
US9427476B2 (en) | 2012-05-24 | 2016-08-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Multivalent meningococcal conjugates and methods for preparing conjugates |
AU2013295242C1 (en) | 2012-07-27 | 2018-08-09 | Institut National De La Sante Et De La Recherche Medicale | CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
CA2903716C (en) | 2013-03-08 | 2019-04-09 | Pfizer Inc. | Immunogenic fusion polypeptides |
KR20180099912A (ko) | 2013-09-08 | 2018-09-05 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
US11160855B2 (en) * | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
US10888611B2 (en) | 2015-02-19 | 2021-01-12 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
CN104844712B (zh) * | 2015-04-03 | 2019-06-28 | 长春百克生物科技股份公司 | 肺炎链球菌蛋白抗原及其制备方法和应用 |
CA3008042A1 (en) | 2015-12-10 | 2017-06-15 | National Research Council Of Canada | Lipidated streptococcus pneumoniae antigen compositions, methods of preparation and use |
CA3048981A1 (en) * | 2016-12-30 | 2018-07-05 | Sutrovax, Inc. | Polypeptide-antigen conjugates with non-natural amino acids |
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
HRP20220573T1 (hr) * | 2017-01-20 | 2022-06-10 | Pfizer Inc. | Imunogeni pripravci, namijenjeni upotrebi u pneumokoknim cjepivima |
SG10202111092UA (en) | 2017-01-31 | 2021-11-29 | Pfizer | Neisseria meningitidis compositions and methods thereof |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
CN107961370B (zh) * | 2017-03-22 | 2020-08-11 | 武汉博沃生物科技有限公司 | 多价肺炎球菌缀合疫苗及其制备方法 |
WO2020009993A1 (en) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Improvements in immunogenic conjugates |
Family Cites Families (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4057685A (en) | 1972-02-02 | 1977-11-08 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
US4459286A (en) | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
US4663160A (en) | 1983-03-14 | 1987-05-05 | Miles Laboratories, Inc. | Vaccines for gram-negative bacteria |
US4761283A (en) | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
IT1187753B (it) | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
US5204098A (en) | 1988-02-16 | 1993-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Polysaccharide-protein conjugates |
NL8802046A (nl) | 1988-08-18 | 1990-03-16 | Gen Electric | Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen. |
CA2005704C (en) | 1988-12-16 | 2003-02-11 | James C. Paton | Pneumolysin mutants and pneumococcal vaccines made therefrom |
US6716432B1 (en) | 1988-12-16 | 2004-04-06 | James Cleland Paton | Pneumolysin mutants and pneumococcal vaccines made therefrom |
ES2055785T3 (es) | 1989-01-17 | 1994-09-01 | Eniricerche Spa | Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas. |
WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
CA2063271A1 (en) | 1989-07-14 | 1991-01-15 | Subramonia Pillai | Cytokine and hormone carriers for conjugate vaccines |
IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
IL98715A0 (en) | 1990-08-13 | 1992-07-15 | American Cyanamid Co | Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines |
IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
IL102687A (en) | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
US5425946A (en) | 1992-08-31 | 1995-06-20 | North American Vaccine, Inc. | Vaccines against group C Neisseria meningitidis |
DK0658118T3 (da) | 1992-08-31 | 2002-05-06 | Baxter Healthcare Sa | Vaccine mod Neisseria meningitidis, gruppe C |
NL9201716A (nl) | 1992-10-02 | 1994-05-02 | Nederlanden Staat | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
AU5543294A (en) | 1993-10-29 | 1995-05-22 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
US5698438A (en) | 1994-10-18 | 1997-12-16 | Oregon Health Sciences University | Bacterial hemoglobin receptor gene |
IL117483A (en) | 1995-03-17 | 2008-03-20 | Bernard Brodeur | MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K. |
AU6909098A (en) | 1996-10-31 | 1998-05-22 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
US6080725A (en) | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
WO1998053851A1 (en) | 1997-05-28 | 1998-12-03 | University Of Iowa Research Foundation | Laft mutants of pathogenic gram-negative bacteria |
GB9713156D0 (en) | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
US6764686B2 (en) | 1997-07-21 | 2004-07-20 | Baxter International Inc. | Modified immunogenic pneumolysin compositions as vaccines |
US6645503B1 (en) | 1998-03-10 | 2003-11-11 | Wyeth Holdings Corporation | Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria |
DE19814925C2 (de) * | 1998-04-03 | 2000-10-05 | Thomas Harrer | Arzneimittel zur Induktion zytotoxischer T-Zellen |
EP1073450A4 (en) | 1998-04-23 | 2003-04-23 | Uab Research Foundation | PNEUMOCOCCAL SURFACE PROTEIN C (PSPC), EPITOPIC REGIONS, SELECTION OF CORRESPONDING STRES AND USES |
EP2261347A3 (en) | 1998-05-01 | 2012-01-11 | Novartis Vaccines and Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
DE69941574D1 (de) | 1998-08-19 | 2009-12-03 | Baxter Healthcare Sa | Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid |
WO2000023595A1 (en) | 1998-10-22 | 2000-04-27 | The University Of Montana | Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
ES2294821T5 (es) | 1998-11-03 | 2014-03-05 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | LPS con toxicidad reducida a partir de bacterias gram negativas modificadas genéticamente |
AU1626199A (en) | 1998-12-04 | 2000-06-26 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | A vi-repa conjugate vaccine for immunization against salmonella typhi |
CA2355364C (en) | 1998-12-21 | 2014-03-18 | Medimmune, Inc. | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
AR022963A1 (es) | 1999-03-19 | 2002-09-04 | Smithkline Beecham Biolog | Vacuna |
WO2000061761A2 (en) | 1999-04-09 | 2000-10-19 | Techlab, Inc. | Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
CN100392082C (zh) | 1999-04-30 | 2008-06-04 | 启龙股份公司 | 保守的奈瑟球菌抗原 |
US6531131B1 (en) | 1999-08-10 | 2003-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for Neisseria meningitidis |
GB9925559D0 (en) | 1999-10-28 | 1999-12-29 | Smithkline Beecham Biolog | Novel method |
ATE460484T1 (de) | 1999-11-29 | 2010-03-15 | Novartis Vaccines & Diagnostic | 85 kda antigen von neisseria |
WO2001055182A1 (en) | 2000-01-25 | 2001-08-02 | The University Of Queensland | PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA |
GB0007432D0 (en) | 2000-03-27 | 2000-05-17 | Microbiological Res Authority | Proteins for use as carriers in conjugate vaccines |
AU2001287645A1 (en) | 2000-07-20 | 2002-02-05 | Hansa Medical Ab | Fh-binding protein of streptococcus pneumiae |
GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
WO2002091998A2 (en) | 2001-05-11 | 2002-11-21 | Aventis Pasteur, Inc. | Novel meningitis conjugate vaccine |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
US20050147624A1 (en) | 2002-02-22 | 2005-07-07 | Harold Jennings | Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue |
JP2005526153A (ja) | 2002-03-26 | 2005-09-02 | カイロン ソチエタ ア レスポンサビリタ リミタータ | 水中において改善された安定性を持つ修飾糖 |
DE60313163T2 (de) | 2002-06-11 | 2008-01-03 | Glaxosmithkline Biologicals S.A. | Immunogene zusammensetzungen |
US20060034854A1 (en) | 2002-08-02 | 2006-02-16 | Berthet Francois-Xavier J | Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria |
DE60335477D1 (de) | 2002-10-11 | 2011-02-03 | Novartis Vaccines & Diagnostic | Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien |
CA2504938C (en) | 2002-11-07 | 2011-10-11 | Synergy America, Inc. | Compositions and methods for treating or preventing pneumococcal infection |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
AU2004230244B2 (en) | 2003-04-15 | 2011-09-22 | Intercell Ag | S. pneumoniae antigens |
GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
US20050112139A1 (en) * | 2003-10-23 | 2005-05-26 | Nmk Research, Llc | Immunogenic composition and method of developing a vaccine based on factor H binding sites |
KR20070008625A (ko) | 2004-04-05 | 2007-01-17 | 화이자 프로덕츠 인코포레이티드 | 미세유체화된 수중유 유화액 및 백신 조성물 |
GB0408977D0 (en) * | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
GB0410220D0 (en) | 2004-05-07 | 2004-06-09 | Kirkham Lea Ann | Mutant pneumolysin proteins |
GB0419408D0 (en) * | 2004-09-01 | 2004-10-06 | Chiron Srl | 741 chimeric polypeptides |
CA2590974C (en) * | 2005-01-27 | 2017-10-03 | Children's Hospital & Research Center At Oakland | Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
PL3466982T3 (pl) | 2005-04-08 | 2020-11-02 | Wyeth Llc | Usuwanie zanieczyszczeń z polisacharydu streptococcus pneumoniae poprzez zmianę ph |
IL308456A (en) | 2005-04-08 | 2024-01-01 | Wyeth Llc | A multivalent pneumomuroral protein-polysaccharide conjugate preparation |
US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
PE20110072A1 (es) | 2005-06-27 | 2011-02-04 | Glaxosmithkline Biolog Sa | Composicion inmunogenica |
US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
CA2816182C (en) * | 2005-12-22 | 2018-02-20 | Glaxosmithkline Biologicals S.A. | Pneumococcal polysaccharide conjugate vaccine |
EP2004225B1 (en) * | 2006-03-22 | 2012-04-25 | Novartis AG | Regimens for immunisation with meningococcal conjugates |
TW200806315A (en) * | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
CA2654709A1 (en) | 2006-06-12 | 2007-12-21 | Nathalie Devos | Neisseria meningitidis lipooligosaccharide vaccine |
ATE473289T1 (de) | 2006-10-10 | 2010-07-15 | Wyeth Llc | Verbesserte verfahren zur trennung von streptococcus pneumoniae-3-polysacchariden |
BRPI0717219B8 (pt) | 2006-10-12 | 2021-05-25 | Glaxosmithkline Biologicals Sa | composição imunogênica, e, uso de uma composição imunogênica |
EP1923069A1 (en) | 2006-11-20 | 2008-05-21 | Intercell AG | Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
BRPI0811979A2 (pt) * | 2007-06-04 | 2014-10-21 | Novartis Ag | Formulação para vacinas de meningite |
WO2009038889A1 (en) * | 2007-08-02 | 2009-03-26 | Children's Hospital And Research Center At Oakland | Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
NZ595234A (en) * | 2009-03-24 | 2013-12-20 | Novartis Ag | Adjuvanting meningococcal factor h binding protein |
-
2010
- 2010-03-24 WO PCT/IB2010/000734 patent/WO2010109324A1/en active Application Filing
- 2010-03-24 NZ NZ595291A patent/NZ595291A/xx not_active IP Right Cessation
- 2010-03-24 CN CN2010800235863A patent/CN102438649A/zh active Pending
- 2010-03-24 AU AU2010227220A patent/AU2010227220B2/en not_active Ceased
- 2010-03-24 BR BRPI1009829A patent/BRPI1009829A2/pt not_active Application Discontinuation
- 2010-03-24 JP JP2012501409A patent/JP5668049B2/ja not_active Expired - Fee Related
- 2010-03-24 RU RU2011142774/10A patent/RU2555757C2/ru not_active IP Right Cessation
- 2010-03-24 EP EP20100716044 patent/EP2411045A1/en not_active Withdrawn
- 2010-03-24 US US13/260,548 patent/US20120064103A1/en not_active Abandoned
- 2010-03-24 EP EP15194612.6A patent/EP3017826A1/en not_active Withdrawn
- 2010-03-24 CA CA2756533A patent/CA2756533A1/en not_active Abandoned
-
2011
- 2011-09-23 CL CL2011002369A patent/CL2011002369A1/es unknown
-
2014
- 2014-10-28 JP JP2014219043A patent/JP2015028081A/ja not_active Withdrawn
-
2015
- 2015-07-31 CL CL2015002157A patent/CL2015002157A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3017826A1 (en) | 2016-05-11 |
EP2411045A1 (en) | 2012-02-01 |
NZ595291A (en) | 2013-08-30 |
RU2011142774A (ru) | 2013-04-27 |
CL2011002369A1 (es) | 2012-02-17 |
AU2010227220A1 (en) | 2011-10-13 |
JP5668049B2 (ja) | 2015-02-12 |
AU2010227220B2 (en) | 2014-11-13 |
CL2015002157A1 (es) | 2016-01-15 |
JP2012521403A (ja) | 2012-09-13 |
CA2756533A1 (en) | 2010-09-30 |
RU2555757C2 (ru) | 2015-07-10 |
US20120064103A1 (en) | 2012-03-15 |
WO2010109324A1 (en) | 2010-09-30 |
WO2010109324A9 (en) | 2010-12-29 |
CN102438649A (zh) | 2012-05-02 |
JP2015028081A (ja) | 2015-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1009829A2 (pt) | combinações de proteína de ligação de fator h meningocócico e conjugados de sacarídeos pneumocócicos | |
IL284184A (en) | Oligosaccharide-protein conjugates | |
HK1215189A1 (zh) | 多價肺炎球菌多糖-蛋白綴合物組合物 | |
BRPI0917000A2 (pt) | proteínas conjugadas com eficácia in vivo prolongada | |
BRPI1013688A2 (pt) | proteínas de ligação de il-17. | |
HK1171691A1 (zh) | 血液凝結蛋白綴合物 | |
BRPI1010620A2 (pt) | métodos de conjugação | |
BRPI1012340A8 (pt) | proteínas de ligação específica e usos das mesmas | |
EP2170363A4 (en) | TISSUE-SPECIFIC PEPTIDE CONJUGATES AND METHOD | |
BRPI0908047A2 (pt) | Gel de carboidrato | |
ZA201001206B (en) | Saccharide-containing protein conjugates and uses thereof | |
BRPI0923191A2 (pt) | metodos relacionados com glicanos modificados | |
BRPI1006058A2 (pt) | "fermentação de carboidrato" | |
PL2459224T3 (pl) | Koniugaty białka związanego z krzepnięciem krwi | |
EP2155792A4 (en) | OLIGONUCLEOTIDE CONJUGATE OF PROTEIN G | |
BRPI0815604A2 (pt) | Proteínas de streptococcus imunogênicas | |
BRPI0819765A2 (pt) | Conjugados de anticorpos anti-rg-1 | |
BRPI0915517A2 (pt) | sacarídeos vi conjugados | |
DK2276850T3 (da) | Irx-2-modificeret fremstillingsfremgangsmåde | |
BRPI0909096A2 (pt) | uso de conjugados de interleicna-1 no tratamento de diabetes | |
BRPI0816364A2 (pt) | injetável, solução de injeção e kit de preparação da injeção | |
DK2509593T3 (da) | Protein-polymer-konjugater | |
BRPI0911722A2 (pt) | conjugado de peptídeo-polímero | |
SI2459224T1 (sl) | Konjugati krvnega koagulacijskega proteina | |
IT1391501B1 (it) | Scheda elettorale anti-annullamento e anti-broglio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |